Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Hogan

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Cancer Research|June 18, 2009
Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancerTatsuyoshi Funasaka, Victor Hogan, Avraham Raz
Glycobiology|January 10, 2018
Galectin-3 and cancer stemnessPratima Nangia-Makker, Victor Hogan, Avraham Raz
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 30, 2005
Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxiaTatsuyoshi Funasaka, Takashi Yanagawa, Victor Hogan, et al.
The Journal of Biological Chemistry|October 24, 2006
Importin-mediated nuclear translocation of galectin-3Susumu Nakahara, Victor Hogan, Hidenori Inohara, et al.
The Journal of Biological Chemistry|October 11, 2007
Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescenceTatsuyoshi Funasaka, Huankai Hu, Victor Hogan, et al.
Cancer Research|January 9, 2003
Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblastsSoichi Tsutsumi, Victor Hogan, Ivan R Nabi, et al.
Trends in Molecular Medicine|April 3, 2002
Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agentsPratima Nangia-Makker, Jeffrey Conklin, Victor Hogan, et al.
Journal of Bioenergetics and Biomembranes|February 24, 2007
Galectin-3 in apoptosis, a novel therapeutic targetPratima Nangia-Makker, Susumu Nakahara, Victor Hogan, et al.
The Journal of Biological Chemistry|October 22, 2022
Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseasesPratima Nangia-Makker, Victor Hogan, Vitaly Balan, et al.
Cancer Research|August 26, 2017
Cancer Self-Defense: An Immune StealthKosei Nakajima, Pratima Nangia-Makker, Victor Hogan, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Cancer Research|June 18, 2009
Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancerTatsuyoshi Funasaka, Victor Hogan, Avraham Raz
Glycobiology|January 10, 2018
Galectin-3 and cancer stemnessPratima Nangia-Makker, Victor Hogan, Avraham Raz
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 30, 2005
Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxiaTatsuyoshi Funasaka, Takashi Yanagawa, Victor Hogan, et al.
The Journal of Biological Chemistry|October 24, 2006
Importin-mediated nuclear translocation of galectin-3Susumu Nakahara, Victor Hogan, Hidenori Inohara, et al.
The Journal of Biological Chemistry|October 11, 2007
Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescenceTatsuyoshi Funasaka, Huankai Hu, Victor Hogan, et al.
Cancer Research|January 9, 2003
Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblastsSoichi Tsutsumi, Victor Hogan, Ivan R Nabi, et al.
Trends in Molecular Medicine|April 3, 2002
Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agentsPratima Nangia-Makker, Jeffrey Conklin, Victor Hogan, et al.
Journal of Bioenergetics and Biomembranes|February 24, 2007
Galectin-3 in apoptosis, a novel therapeutic targetPratima Nangia-Makker, Susumu Nakahara, Victor Hogan, et al.
The Journal of Biological Chemistry|October 22, 2022
Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseasesPratima Nangia-Makker, Victor Hogan, Vitaly Balan, et al.
Cancer Research|August 26, 2017
Cancer Self-Defense: An Immune StealthKosei Nakajima, Pratima Nangia-Makker, Victor Hogan, et al.
Pageof 4